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Summary
Introduction. Pneumonia is a common childhood lower respiratory tract infection, which accounts for large number of hospitalization 
and death among children; its diagnosis is based mainly on clinical signs.
Aim of the study was to measure inflammatory cytokine panels in children with pneumonia, and their correlation with clinically used 
inflammatory markers.
Materials and methods. We included 20 patients, hospitalized in Children’s Clinical University hospital, with systemic inflammatory 
response syndrome (SIRS) and radiologically confirmed pneumonia from October 2011 to January 2013. In all patients cytokine 
and chemokine panels and clinical inflammatory markers were measured at the time of admission, after 24 hours and on the time 
of discharge.
Results. 12 different inflammatory cytokines were measured. sFAS, sVCAM1, IL-8, IL-10, TNF alpha, Eotaxin, G-CSF, IL1ra, IP10 
and MCP1 showed statistically significant changes between levels of inclusion in the study and levels after 24 hours. G-CSF, IL-8, 
IFN gamma, TNF alpha and IL-10 showed also medium strong correlation with clinically used inflammatory markers (PCT, CRO, 
and IL-6).
Conclusions. Inflammatory cytokines show statistically significant changes during course of treatment, thus they could be used in 
diagnostics in septic patients with pneumonia, and also could show patients response to therapy.
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and bacterial pneumonias, but they might be used in 
hospitalized children with more serious disease, to 
determinate course of disease and efficacy of treatment 
(5). Cytokine and chemokine response in children 
with pneumonia has been more studied during the 
outbreak of H1N1 influenza period, where in patients 
with pneumonia, the serum levels of interferon gamma 
(IFN gamma), interleukin-5 (IL-5), interleukin-6 
(IL-6),interleukin-8 (IL-8), interleukin-10 (IL-10), 
interleukin-13 (IL-13), and monocyte chemoattractant 
protein-1 (MCP-1) were significantly higher than those 
in patients without pneumonia (7, 11); thus they might 
be investigated as novel diagnostic markers in children 
with pneumonia. In Latvia no studies of determining 
cytokine and chemokine levels in children with 
pneumonia were performed.
AIM OF THE STUDY 
Was to determine inflammatory cytokine and 
chemokine panels, and their dynamical change in 
the course of treatment in hospitalized children with 
systemic inflammatory response syndrome (SIRS) 
and radiologically confirmed pneumonia, and their 
correlation with clinically approved inflammatory 
markers – CRP, PCT and IL-6.
MATERIALS AND METHODS
Patient recruitment took place from October 2011 to 
January 2013 in Children’s Clinical University hospital, 
Riga, Latvia.
INTRODUCTION
Pneumonia is a common childhood lower respiratory 
tract infection, it also accounts for large number of 
hospitalization and death among children below 
5 years of age (1). The incidence of community-
acquired pneumonia is reportedly 36–40 episodes per 
1000 children per year in children younger than 5 
years and 11–16 episodes per 1000 children per year 
in children 5–14 years. In Europe alone, 2.5 million 
cases of pneumonia occur annually (2). The etiological 
agents in children are variable, depending on age, in 
different studies they have been shown to be 7 - 65% 
bacterial, 37 – 45% viral, 1-23% mixed agents (8, 12). 
Also, the diagnosis of pneumonia is mostly based on 
clinical signs. Currently available guidelines state, that 
diagnosis of pneumonia should be considered if a child 
has persistent or repetitive fever >38.5 ºC together 
with chest retractions and a raised respiratory rate (3). 
Radiologically confirmed pneumonia plays a significant 
role in clinical diagnosis of sepsis in children. According 
to guidelines by International Consensus Conference 
on Pediatric Sepsis (4), patient can be diagnosed as 
septic, if he or she has inflammatory response syndrome 
(SIRS) together with a confirmed source of infection; 
this confirmation can also be radiological. Concerning 
ancillary testing in pneumonia, guidelines state 
that acute-phase reactants, such as the erythrocyte 
sedimentation rate (ESR), C-reactive protein (CRP), 
or serum procalcitonin (PCT) concentration, cannot 
be used as a determinant to distinguish between viral 
10.2478/chilat-2014-0009
ACTA CHIRURGICA LATVIENSIS • 2013 (13/1)
44
Table 1. Descriptive values of inflammatory markers, cytokines and chemokines, and their dynamics
On the inclusion 24 hours after inclusion On the discharge P value
sFAS
3812,1 ± 1874,5 
(95% CI 2934,8 – 4689,4)
4261,2 ± 1428,3 
(95% CI 3592,7 – 4929,7)
4687,0 ± 1179,2 
(95% CI 4118,6 – 5255,4) < 0,001
sVCAM1
1290,0 ± 977,05 
(95% CI 832,73 – 1747,3)
920,36 ± 647,62 
(95% CI 617,26 – 1223,5)
616,19 ± 261,38 
(95% CI 490,20 – 742,17) < 0,001
tPAI1
101,86 ± 50,35 
(95% CI 78,30 – 125,43)
104,78 ± 51,25 
(95% CI 80,79 – 128,76)
125,78 ± 61,25 
(95% CI 96,26 – 155,31) 0,84
IL-8
102.43 ± 277.02 
(95% CI 31.01 - 235.95)
20.446 ± 26.89 
(95% CI 7,86 – 33,03)
17,54 ± 28,86 
(95% CI 3,18 – 31,89) < 0,001
IL-10
474,84 ± 1617,0 
(95% CI 304,53 – 1254,2)
240,57 ± 747,23
(95% CI 109,14 – 590,29)
41,21 ± 65.94 
(95% CI 8.41– 74.0) < 0,001
INF gamma
22,33 ± 32,48 
(95% CI 6,67 – 37,98)
17,04 ± 27,75 
(95% CI 4,06 – 30,03)
10,32 ± 22,02 
(95% CI 0,63– 21,27) 0,20
TNF alpha
17,73 ± 15,79 
(95% CI 10,11 – 25,33)
13,51 ± 9,27 
(95% CI 9,17 – 17,84)
11,42 ± 9,09 
(95% CI 7,04 – 15,81) < 0,05
Eotaxin 
92,68 ± 74,45 
(95% CI 57,84 – 127,53)
80,82 ± 34,67 
(95% CI 64,59 – 97,05)
108,30 ± 52,25 
(95% CI 83,11 – 108,3) < 0,001
G-CSF
2324,2 ± 3698,9 
(95% CI 593,03 – 4055,3)
307,32 ± 552,05 
(95% CI 48,95 – 565,68)
67,64 ± 80,81 
(95% CI 28,68 – 106,59) < 0,001
IL1ra
57.27± 126.25 
(95% CI 1.81– 116.36)
43.68 ± 1617,0 
(95% CI 9.19 – 96.55)
90.86 ± 231.49 
(95% CI 20.72 – 202.43) 0,95
IP10
2650,8 ± 4676,5 
(95% CI 462,15 – 4839,5)
1412,3± 2177,1 
(95% CI 393,45 – 2431,2)
439,69 ± 259,69 
(95% CI 314,53– 564,86) < 0,001
MCP1
979,77 ± 1039,7 
(95% CI 493,17 – 1466,4)
670,22 ± 903,66 
(95% CI 247,30 – 1093,2)
797,63 ± 1256,1
 (95% CI 192,23 – 1403,0) < 0,001
There were several statistically significant moderate and strong correlations found among PCT, IL-6 and CRP. These 
correlations are depicted in Table 2.
Inclusion criteria were:
1. Hospitalized child with SIRS and sepsis, as 
determined by International Consensus Conference 
on Pediatric Sepsis (4): at least two of below 
mentioned criteria, one of which must be abnormal 
temperature or leukocyte count:
• Core temperature >38.5 or < 36.0 C.
• Tachycardia, defined as a mean heart rate >2SD 
above normal for age; or for children <1yr old, 
bradycardia, defined as a mean heart rate <10th 
percentile for age.
• Mean respiratory rate >2SD above normal for age.
• Leukocyte count elevated or depressed for age or 
>10% immature neutrophils, and
2. Confirmed pneumonia by chest x-ray
Exclusion criteria were antibacterial therapy within 
the last 48 h, immunodeficiency, chronic liver or 
kidney illness, vaccination within 5 days before the 
start of the illness, congenital metabolic defects, 
chromosomal anomalies, and use of corticosteroids or 
immunosuppressant medications, Patients exclusion 
factors from study were obesity, diabetes mellitus, 
chronic inflammatory diseases, such as rheumatoid 
arthritis, systemic lupus erythematosus, vasculitis, 
inflammatory bowel disease, heart diseases, renal or 
liver diseases, or malignancies and other diseases which 
are known to be associated with significant changes 
of anti- and pro-inflammatory biomarkers, including 
surgery or trauma within the preceding 30 days.
In all patients CRP, PCT, IL-6 and inflammatory cytokine 
and chemokine panels (soluble apoptosis- stimulating 
fragment (sFAS), soluble vascular cell adhesion molecule 
(sVCAM-1), total plasminogen activator inhibitor type 
1 (tPAI1), IL-8, IL-10, INF gamma, tumor necrosis 
factor alpha (TNF alpha), Eotaxin, granulocyte colony-
stimulating factor (G-CSF), interleukin-1 receptor 
antagonist (IL-1ra), interferon-inducible protein-10 
(IP10), MCP1) were measured on the time of inclusion, 
after 24 hours and on the discharge.
Data was analysed, using descriptive statistics, groups 
were compared, using chi-square, correlations 
were determined by Pearson correlation coefficient 
(correlation was considered strong, if r > 0,7, moderately 
strong if r >0,4); p values of less than 0,05 were 
considered statistically significant. Data analysis was 
performed on Statistix 9.
RESULTS
In total 20 patients were included – 11 girls and 9 boys. 
Median age of patients were 70 months, respectively, 
5 years and 10 months (minimal age value 8 months, 
maximal 207 months (17 years and 3 months), mean 
age value 86,4). Patients were included in the study 
on the median 4,5th day of illness (minimal value 2, 
maximal 8 days, mean 4,75). 10% (2) of patients had 
severe sepsis, 10% (2) had septic shock, all these patients 
were treated in the intensive care unit (ICU), and one 
patient received artificial lung ventilation during ICU 
stay. 20% (4) patients had pleural effusion that required 
surgical drainage. All patients received intravenous 
rehydration therapy and antibacterial therapy – 30% 
(6) received one antibacterial preparation, 65% (13) 
received combined antibacterial therapy with two 
or more preparations, but in 5% (1) the antibacterial 
therapy was changed during the course of treatment. 
The descriptive values of inflammatory cytokines and 
chemokines can be seen in Table 1
ACTA CHIRURGICA LATVIENSIS • 2013 (13/1)
45
Table 2. Correlations among clinical inflammatory markers and inflammatory cytokines and chemokines 
(correlation coefficient r, statistical significance)
On inclusion
CRP PCT IL-6
TNF alpha 0,51 (p=0,03) 0,66 (p=0,002)




G-CSF 0,48 (p=0,03) 0,75 (p<0,001)
IL-8 0,69 (p<0,001)
IFN gamma 0,52 (p=0,18)
On discharge
CRP PCT IL-6
G-CSF 0,86 (p=0,01) 0,54 (p=0,02) 0,82 (p<0,001)
IL-10 0,82 (p<0,001) 0,66 (p=0,003)
IL-8 0,64 (p=0,004)
There was also a moderately strong positive correlation between length of stay in the hospital and levels of TNF alpha 
(r=0,6, p=0,01), sFAS (r=0,59, p=0,01), sVCAM1 (r=0,50, p=0,04), MCP1 (r=0,53, p=0,03), IL-10 (r=0,52, p=0,03) 
at inclusion of the study.
Moderately strong positive correlations were found between age and sFAS (r=0,69, p=0,002), INF gamma (r=0,65, 
p=0,005) at inclusion of the study.
DISCUSSION
This study had several limitations – limited patient 
count and no control group. Several other studies have 
focused on changes of cytokine levels, grouped by 
etiological factors, for example, Takano et al. studied 
cytokine and chemokine response in children with H1N1 
influenza pneumonia, where they found significantly 
higher elevated levels of IFN-γ, IL-6, IL-8, IL-10, IL-
13, MCP-1 and IL-5 in patients with pneumonia than 
those without pneumonia (13). Another study, which 
included patients with H1N1 influenza, found that 
serum concentrations of INF –γ, TNF alpha, IL-4, and 
IL-2 were significantly lower in pneumonia patients 
with neutrophilic leukocytosis than in those without 
neutrophilic leukocytosis (7). Our study did not analyse 
cytokine levels in connection with leukocyte count, and 
there was just one patient group.
Ballin et al. studied inflammatory cytokine levels 
in children and adults with community acquired 
bronchopneumonia, where they found, that age was 
directly correlated with levels of IL-8 and G-CSF (1); 
whereas we did not find such kind of association in this 
study, positive correlation was found between age and 
levels of sFAS and INF gamma. 
There have been several studies of inflammatory 
cytokines in adults with pneumonia and/or sepsis. 
Kellum et al. included 1886 patients with pneumonia 
and/or sepsis in a multicentre study, and measured levels 
of TNF alpha, IL-6 and IL-10. Patients were divided into 
3 groups – patients who did not develop severe sepsis, 
patients with severe sepsis who died, and patients with 
severe sepsis who survived. Authors found, that in 
patients, who had severe sepsis, cytokine levels were 
higher than in those who had just pneumonia; also 
cytokine levels were higher in those patients, who had 
severe sepsis and died, than in those who survived (9). 
Also, Lee et al conducted a study with adult patients 
with severe community acquired pneumonia, who were 
treated in in ICU. Similarly, they found higher levels of 
TNF alpha, IL-6, IL-8, IL-10 in non-survivors than in 
survivors, also patients who developed acute respiratory 
distress syndrome had higher IL-6, IL-8 and IL-10 levels 
(10). Our study included patients with sepsis, but due 
to limited patient count we were not able to analyse 
cytokine levels between patient groups with sepsis 
and severe sepsis, but there was a correlation between 
inflammatory cytokine levels and length of stay in the 
hospital, which could indirectly note the severity of 
illness. 
We found moderately strong correlation between G-CSF 
and PCT, and IL-6 on inclusion, which promotes the idea 
Horisberger et al., which have initiated a randomized 
controlled trial of G-CSF and IL-8 as markers for early 
diagnostics of sepsis in critically ill children (6). 
CONCLUSIONS
sFAS, sVCAM1, IL-8, IL-10, TNF alpha, Eotaxin, G-CSF, 
IL1ra, IP10 and MCP1 showed statistically significant 
changes between levels of inclusion in the study and 
levels after 24 hours, indicating they could be used in 
diagnostics in septic patients with pneumonia, and also 
show patients response to therapy. 
Also, G-CSF, IL-8 had moderately strong or strong 
correlations with clinically used inflammatory markers 
on different time points of the study, these markers 
should be further investigated as early diagnostic 
markers for children with sepsis.
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